Instalab

Dog (Can f_Fd1) IgE Test Blood

A precise read on true dog allergy, sharper than a standard dog dander panel.

Should you take a Dog (Can f_Fd1) IgE test?

This test is most useful if any of these apply to you.

Living With Asthma That Flares Around Dogs
Pinpoint whether dog is genuinely driving your symptoms and whether you may qualify for targeted treatments like immunotherapy or biologics.
Got Positive Results on a Standard Pet Panel
Tell whether your dog result reflects true allergy or cross-reactivity from cat proteins, before making decisions about your pets.
Watching Your Child Develop Pet Symptoms
See whether early sensitization is likely to become persistent dog allergy as your child grows.
Considering Getting a Dog
Find out whether your body already recognizes dog proteins before bringing one home, especially with prior allergies or asthma.

About Dog (Can f_Fd1) IgE

If you live with a dog, sneeze around dogs, or have asthma that flares in homes with pets, the question is not whether you can feel symptoms. The question is whether dog is actually the trigger, and how confident you can be in that answer. This test looks for a single, highly specific antibody your immune system makes against one of the main proteins in dog dander and saliva.

A standard dog allergy blood test uses a crude mix of dog proteins, which can produce results that are hard to interpret when you are also sensitized to cats or other furry animals. This test isolates one component of that mix, giving you a cleaner signal about whether your body is genuinely reacting to dog itself.

What Can f 1 Actually Is

Can f 1 (Canis familiaris allergen 1) is one of the main proteins in dog dander, the microscopic flakes of skin dogs shed constantly. It belongs to a protein family called lipocalins, which are small carrier proteins found in the dander, saliva, and urine of many mammals. In dog-allergic people, Can f 1 is one of the most commonly recognized dog proteins. Among confirmed dog-allergic patients in one component-resolved study, about half had IgE (immunoglobulin E, the antibody class responsible for allergic reactions) against Can f 1.

This test measures the level of IgE in your blood that specifically targets Can f 1. A higher level means your immune system has produced more antibodies against this protein, which it has come to treat as a threat. That recognition is what drives sneezing, itching, hives, and asthma when you are exposed.

Why It Beats Standard Dog Extract Testing

The conventional dog allergy test uses an extract made from whole dog dander, which contains a mixture of proteins in varying amounts that can differ between manufacturers. A positive result tells you that you react to something in dog, but not which protein, and not whether your reaction will lead to real-world symptoms.

In a large birth cohort followed into adolescence, IgE to Can f 1 in childhood was associated with dog allergy symptoms in adolescence. Sensitization to Can f 1 was identified as an independent predictor of dog allergy symptoms up to age 16. In other words, a positive Can f 1 result was more likely to mean genuine, lasting dog allergy than a positive standard dog test.

Predicting Future Dog Allergy

For children who have not yet developed clear-cut allergy symptoms, Can f 1 IgE carries predictive weight. The BAMSE/MeDALL birth cohort study found that childhood sensitization to Can f 1 predicted dog allergy symptoms in adolescence better than IgE to whole dog extract did. This is useful for families with young children who are around dogs and want to understand which kids are likely to develop persistent issues.

In children already sensitized to dog dander, sensitization to more dog allergen components, especially the lipocalin family, was associated with a positive nasal provocation test. The more components your immune system recognizes, the more likely a real-world dog exposure will trigger symptoms.

Connection to Asthma Severity

Dog sensitization is not only about itchy eyes and runny noses. In dog-sensitized children, polysensitization to multiple furry animal proteins and higher IgE levels to dog lipocalins (specifically Can f 2, Can f 4, and Can f 6) were linked to more asthma and more troublesome asthma. In adults with severe asthma, Can f 1 sensitization has been associated with worse asthma control scores.

Among children with severe asthma, broad molecular profiling revealed more complex polysensitization patterns to animal proteins than standard testing would have shown. In one analysis using a multiplex molecular test, about one in five severe asthma patients qualified for anti-IgE biologic treatment, with canine and other sensitizations meaningfully affecting asthma control.

What this means for you: if you have asthma that is hard to control and you live with a dog or are regularly around one, knowing whether Can f 1 IgE is present can change the conversation with your clinician about avoidance, allergen immunotherapy, or biologic therapy.

Cross-Reactivity With Cats and Other Animals

Can f 1 belongs to the lipocalin family of proteins, which appear across many mammals. The cat lipocalin Fel d 7 cross-reacts with Can f 1. In one study, a high proportion of Fel d 7-positive patients also had IgE to Can f 1, with a moderate link between their IgE levels. Structural similarities between the two proteins and shared regions that immune cells recognize were confirmed, and laboratory cell tests showed both could activate immune responses.

This matters for interpretation. If you test positive for both dog and cat in a standard panel, component testing can tell you whether you are truly sensitized to both species or whether one result reflects cross-reactivity from the other. In one study of dog-exclusive owners co-sensitized to dog and cat on standard tests, measuring Fel d 1 IgE (the major cat-specific protein) helped distinguish true cat sensitization from cross-reactive false positivity.

What Counts as Polysensitization

Dog allergy is rarely about one protein in isolation. Component-resolved studies have shown that dog-allergic patients often recognize multiple dog proteins, with Can f 1, Can f 2, Can f 3, Can f 4, Can f 5, and Can f 6 each contributing to overall sensitization patterns. The exact proportions vary by study population, but Can f 1 and Can f 5 are consistently among the most frequently recognized.

What this means for you: a positive Can f 1 result is consistent with the most common dog allergy pattern. Recognizing multiple dog proteins suggests broader sensitization, which research has linked to more severe respiratory symptoms.

How This Compares to Skin Prick Tests

Skin prick testing with dog extract remains a common first step in allergy clinics. Extract-based skin prick tests tend to be more sensitive than blood-based molecular tests, meaning they are less likely to miss a sensitization. Molecular tests like Can f 1 IgE tend to be more specific, meaning a positive result is more likely to reflect clinically relevant allergy. The two approaches answer different questions: skin testing screens broadly for any reaction, while Can f 1 IgE confirms whether the dog-specific signal is real.

Tracking Your Trend

A single Can f 1 IgE result is a snapshot. IgE levels can shift with ongoing exposure, with avoidance, or with treatment such as allergen immunotherapy. If you are starting immunotherapy for dog allergy, beginning a biologic medication for asthma, or making major changes to your home environment, retesting helps you see whether the underlying sensitization is moving.

A reasonable trending cadence is a baseline test, a follow-up at 6 to 12 months if you are actively making changes, and an annual recheck thereafter. Because no large studies have characterized within-person variability of dog component IgE, treat any single reading in the context of your symptoms, not as a fixed number.

What an Unexpected Result Should Make You Do

If your Can f 1 IgE is positive and you have dog-related symptoms, the next step is an allergy or immunology consult to discuss avoidance strategies, allergen immunotherapy, and, in the case of moderate to severe asthma, whether biologic therapy targeting IgE-driven inflammation is appropriate. A positive result combined with severe or poorly controlled asthma is a particularly strong reason to seek a specialist, since matching the trigger to the treatment can change outcomes.

If your Can f 1 IgE is positive but you have no symptoms, that means sensitization without overt allergy. You may develop symptoms later, particularly with sustained exposure. This is a watching brief, not an emergency. Retest if symptoms appear.

If your Can f 1 IgE is negative but you suspect dog allergy, consider testing other dog components, especially Can f 5 (a dog-specific protein found mainly in male dogs) and the dog lipocalins Can f 2, Can f 4, and Can f 6. Standard dog dander IgE and skin prick testing can also help, since extract testing remains more sensitive. The combination of component, extract, and clinical history gives the most complete picture.

When Results Can Be Misleading

A few factors can complicate interpretation:

  • Cross-reactivity with cat lipocalins: if you are sensitized to cat Fel d 7, you may also test positive for Can f 1 even if dog is not your primary trigger. Component testing for both species clarifies which is the real driver.
  • Co-sensitization patterns: Can f 1 alone does not reveal whether you also react to other dog proteins like Can f 5 or the lipocalin family, which carry their own implications for asthma severity.
  • Asymptomatic sensitization: a positive IgE result without symptoms means your immune system recognizes the protein, but you may not have clinical allergy. The result is informative for future risk, not a definitive diagnosis.

Frequently Asked Questions

References

11 studies
  1. Asarnoj a, Hamsten C, Wadén K, Lupinek C, Andersson N, Kull I, Curin M, Anto J, Bousquet J, Valenta R, Wickman M, Van Hage MThe Journal of Allergy and Clinical Immunology2016
  2. Curin M, Swoboda I, Wollmann E, Lupinek C, Spitzauer S, Van Hage M, Valenta RThe Journal of Allergy and Clinical Immunology2014
  3. Apostolović D, Sánchez-vidaurre S, Wadén K, Curin M, Grundström J, Gafvelin G, Velickovic T, Grönlund H, Thomas W, Valenta R, Hamsten C, Van Hage MAllergy2016
  4. Käck U, Van Hage M, Grönlund H, Lilja G, Asarnoj a, Konradsen JClinical and Translational Allergy2022
  5. Käck U, Asarnoj a, Grönlund H, Borres M, Van Hage M, Lilja G, Konradsen JThe Journal of Allergy and Clinical Immunology2018